Want to contact an Enbrel lawyer in Washington, DC? ...Get a free case evaluation from one of our Enbrel lawyers in Washington, DC now.
Home : Unsafe Drugs : Enbrel : News Articles
Enbrel - News Articles
-
May 12, 2008
Pharma Times (subscription), UK -
for RA – Abbott Laboratories’ Humira (adalimumab), Johnson & Johnson/Schering-Plough’s Remicade (infliximab) and Wyeth/Amgen’s Enbrel (etanercept). ... -
May 10, 2008
TopNews, India -
Washington, May 11 : A new study has shed light on the effectiveness of medication given to children with juvenile rheumatoid arthritis (JRA), often thought to be incapable of treating the disease. Children with JRA are being treated with the same drugs ... -
May 26, 2008
Archives of Internal Medicine -
In the primary model, the n-of-1 trial option was 15% more expensive than stepped care but 47% cheaper than open access to etanercept. More research is needed on the acceptability, safety, and generalizability of this promising approach. ... -
May 8, 2008
Genetic Engineering News (press release), NY -
Juvenile rheumatoid arthritis (JRA) is a chronic autoimmune disease that strikes children between the ages of newborn to 16 years. All children with JRA have joint pain, stiffness, and swelling and some also have fever and skin rashes. ... -
May 9, 2008
DG News -
NEW YORK -- May 9, 2008 -- Study results published in the May 9 issue of Arthritis & Rheumatism support the potential of etanercept therapy to give children with juvenile rheumatoid arthritis (JRA) the promise of a better quality of life as adults. ... -
May 25, 2008
Daytona Beach News-Journal, FL -
Biologic agents, anti-TNF (anti-tumor necrosis factor), such as Enbrel, Humira, and Remicade have proven very effective in treating AS by blocking TNF and reducing inflammation. For most patients, AS's long-term outlook is very good. With the benefits of NSAIDs, biologic agents, physical ... -
Monday, June 02, 2008
PharmaLive.com (press release), PA -
Investment thesis: We believe the risks to the ESA franchise and competitive threats to Enbrel, Denosumab, and the NEUPO franchise are priced in. ANALYST CERTIFICATION All of the recommendations and views about the securities and companies in this report accurately ... -
May 28, 2008
Tort Deform, NY -
In a lawsuit, Marc Engelman accuses the biotech of forcing reps to engage in off-label promotion and patient privacy violations to market the Enbrel medication for psoriasis. But he also charges the arbitration agreement is “procedurally unconscionable” and names the American Arbitration Association ... -
Tuesday, June 03, 2008
Business Report, South Africa -
This was in respect of the biologics Enbrel and Humira. The association said rheumatoid arthritis patients had also been charged co-payments of 30 percent by Spectramed, and 46 percent by Liberty Life Medical Scheme. "Boarded or unemployed due to their ... -
May 29, 2008
Gloucester County Times - NJ.com, NJ -
Madeline is currently being treated with eight medications including Enbrel, a medicine usually used to treat juvenile idiopathic arthritis that behaves similarly to the Tumor Necrosis Factor Receptor, which is not present in the disorder. There are significant risks associated ...
-
May 26, 2008
Providence Journal, RI -
By Paul Edward Parker Chemists John McCrillis and Jasmine Zhang work on water samples inside the chemical lab at Alexion Pharmaceuticals, which is opening a manufacturing plant in Smithfield. The Providence Journal / Steve Szydlowski Volumetric ... -
May 23, 2008
PR Newswire UK (press release), UK -
New data from key clinical trials presented today at the 5th European Academy of Dermatology and Venereology (EADV) Spring Symposium in Istanbul, demonstrate that Enbrel(R) (etanercept) is a convenient and effective treatment which helps patients achieve sustained and repeatable reprieve from ... -
May 23, 2008
Medical News Today (press release), UK -
Safety data from 10 years of clinical development and postmarketing experience in patients treated with Raptiva® (efalizumab), presented at the European Academy of Dermatology and Venereology (EADV) congress, have confirmed the favourable safety profile of Raptiva® in long-term treatment of ... -
May 29, 2008
Pharma Times (subscription), UK -
The National Institute for Health and Clinical Excellence yesterday issued new guidances for the National Health Service in England and Wales covering ankylosing spondylitis, anaemia induced by cancer treatment and the management of type 2 diabetes. NICE has recommended two ... -
May 29, 2008
Workplace Law Network (subscription), UK -
The National Institute for Health and Clinical Excellence (NICE) has released guidance warning that, because people of working age are not active enough to benefit their health, employers should encourage employees to increase their levels of physical activity. The ... -
Jun 19, 2007
Lex 18, KY -
(Ivanhoe Newswire) -- Results of a new study show the psoriasis medication etanercept is not only effective, but long-term use of the drug doesn't cause any ... -
Jun 23, 2007
DentalPlans.com, FL -
(HealthNewsDigest.com) - HOUSTON — Patients using the psoriasis medication, etanercept, will not experience added infections or adverse side effects if they use the drug for an extended period of time., according to a study published in the June issue of ... -
Jul 3, 2007
Journal of American Medical Association (subscription), IL -
A prospective open-label pilot study of 8 patients tested the potential of etanercept, a TNF- blocker, in treating steroid-dependent patients with ... -
Jul 4, 2007
DG News -
Nevertheless, their mechanism of action is not identical: alefacept and efalizumab act directly on T cells, while etanercept and infliximab antagonise proinflammatory signalling by tumour necrosis factor alpha (TNF-a). These differences appear to have variable effects in patients with plaque ... -
Jun 19, 2007
Science Daily (press release) -
Science Daily — Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to ...
Want to contact an Enbrel lawyer in Washington, DC? ...Get a free case evaluation from one of our Enbrel lawyers in Washington, DC now.
Pages: 1 2 3 4 5 6 ... Next
